| Literature DB >> 35608817 |
Bradford Greening, Hilary K Whitham, Wade K Aldous, Nancy Hall, Ann Garvey, Steven Mandernach, Emily B Kahn, Patrick Nonnenmacher, Jason Snow, Martin I Meltzer, Sandra Hoffmann.
Abstract
Quantifying the effect of public health actions on population health is essential when justifying sustained public health investment. Using modeling, we conservatively estimated that rapid response to a multistate foodborne outbreak of Salmonella Typhimurium in the United States in 2018 potentially averted 94 reported cases and $633,181 in medical costs and productivity losses.Entities:
Keywords: Salmonella; Salmonella enterica serovar Typhimurium; United States; bacteria; enteric infections; food safety; foodborne illness; health impact assessment; public health economics; quantitative evaluation
Mesh:
Year: 2022 PMID: 35608817 PMCID: PMC9155865 DOI: 10.3201/eid2806.211633
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 16.126
Quantitative analysis of cases averted in a multistate Salmonella enterica serovar Typhimurium outbreak, United States, 2018
| Parameter | Value | Source |
|---|---|---|
| Product included in recall, lb | 20,630 | ( |
| Product marked as recovered, lb (%) | 5,397 (26.2) | (9) |
| Product available for consumption, lb | 15,233 | Calculated |
| Available product consumed, % | 88.5 (82.0–94.5) | ( |
| Product consumed, lb | 13,481 (12,491–14,395) | Calculated |
| Outbreak cases reported | 265 | ( |
| Cases/1,000 lb consumed | 19.66 (18.41–21.22) | Calculated |
| Cases averted | 94 | Calculated |
| Cases averted including underdiagnosis | 2,751 | Calculated ( |
| Hospitalizations averted | 33 | Calculated |
*Values are no. (range) except as indicated.
Estimated economic impact of cases averted in a multistate Salmonella enterica serovar Typhimurium outbreak, United States, 2018*
| Characteristic in underdiagnosis scenario | None | Low | Middle | High |
| Averted cases | ||||
| Underdiagnosis correction factor | 0 | 21.8 | 29.3 | 38.4 |
| No. cases averted | 94 | 2,047 | 2,751 | 3,605 |
| Economic impact of cases averted | ||||
| Medical costs, USD | $601,563 | $673,626 | $699,610 | $731,137 |
| Productivity loss, nonfatal cases | ||||
| Total lost working days | 112.1 | 619.5 | 802.5 | 1,024.5 |
| Total economic loss, USD | $31,618 | $170,901 | $221,123 | $282,059 |
| Total cost of illness, USD | $633,181 | $844,526 | $920,733 | $1,013,196 |
*Data are for base case (middle) scenario for Fraction of Available Product Consumed. Appendix 1 Tables 5, 6 show results using sensitivity analysis scenarios. USD, US dollars.